Undecimal Bio raises $18M seed

◆ Amount

$18M

◆ Announced

13 Oct 2026

◆ Company

◆ Source

◆ The Round

Undecimal Bio raised $18M in seed funding, announced on 13 October 2026, led by 4BIO Capital, IQ Capital, with participation from Verve Ventures, Harel Tech, Entree Capital, Kerna Ventures, Saras Capital. The round is tracked live by Fusion42 as part of the Raise fund database and the Scout startup database.

◆ About Undecimal Bio

AI-enabled platform for RNA medicine delivery beyond the liver using combinatorial chemistry and transformer-based AI. Undecimal Bio is based in United Kingdom and currently at seed stage, operating in Biotech, AI Infrastructure.

◆ Investors

◆ Market context

This funding event is a citable node in Fusion42's market graph: it links Undecimal Bio's Scout profile to the funds behind the round and to related Wire analysis, and is refreshed from public announcements as the round is confirmed or extended. It is the same live market data Arthur reasons over when benchmarking a founder's own raise against what is closing in the market right now.

◆ Explore the market